Vaccines
Vaccines—the silent protectors
Vaccines have revolutionized the control of virus-borne communicable diseases, from polio to COVID-19 to hepatitis A. Modern vaccine production is moving from egg-based to virus-like particles and RNA constructs. YMC enables these new platforms with proven technologies, from our YMC-Triart C18 silica to the industry’s most advanced continuous purification systems based on the patented MCSGP process.
Whether a vaccine is synthesized or cultured, YMC can address its purification needs with:
- TFF membrane systems
- Batch or continuous LPLC and HPLC chromatography systems
- Pre-packed columns
- Bulk column packing materials: RP, IEX, NP, SEC, HIC, Chiral, and more
- Glass and SS (DAC) empty columns
- Bench-top FPLC systems
- Custom process skids for most downstream unit operations
More Resources Related to This Topic
Product Information
Application Search
Use our extensive Applications Search page to mine a dynamically growing collection of over 350 YMC-produced application notes.
The data can be searched by any combination of several variables, including sample classification, compound name (including partial names), and column parameters.
